25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

FSPKF (Fisher & Paykel Healthcare Corporation Limited) Stock Analysis
Buy, Hold or Sell?

Let's analyze Fisher & Paykel Healthcare Corporation Limited together

I guess you are interested in Fisher & Paykel Healthcare Corporation Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Fisher & Paykel Healthcare Corporation Limited’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Fisher & Paykel Healthcare Corporation Limited’s Price Targets

I'm going to help you getting a better view of Fisher & Paykel Healthcare Corporation Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Fisher & Paykel Healthcare Corporation Limited

I send you an email if I find something interesting about Fisher & Paykel Healthcare Corporation Limited.

1. Quick Overview

1.1. Quick analysis of Fisher & Paykel Healthcare Corporation Limited (30 sec.)










1.2. What can you expect buying and holding a share of Fisher & Paykel Healthcare Corporation Limited? (30 sec.)

How much money do you get?

How much money do you get?
$0.58
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
$1.76
Expected worth in 1 year
$1.78
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
$0.60
Return On Investment
2.9%

For what price can you sell your share?

Current Price per Share
$20.70
Expected price per share
$16.93 - $22.59
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Fisher & Paykel Healthcare Corporation Limited (5 min.)




Live pricePrice per Share (EOD)
$20.70
Intrinsic Value Per Share
$-1.21 - $3.83
Total Value Per Share
$0.55 - $5.59

2.2. Growth of Fisher & Paykel Healthcare Corporation Limited (5 min.)




Is Fisher & Paykel Healthcare Corporation Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$1b$3.3m0.3%

How much money is Fisher & Paykel Healthcare Corporation Limited making?

Current yearPrevious yearGrowGrow %
Making money$77.7m$146.7m-$69m-88.8%
Net Profit Margin7.5%15.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Fisher & Paykel Healthcare Corporation Limited (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#65 / 163

Most Revenue
#27 / 163

Most Profit
#28 / 163
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Fisher & Paykel Healthcare Corporation Limited?

Welcome investor! Fisher & Paykel Healthcare Corporation Limited's management wants to use your money to grow the business. In return you get a share of Fisher & Paykel Healthcare Corporation Limited.

First you should know what it really means to hold a share of Fisher & Paykel Healthcare Corporation Limited. And how you can make/lose money.

Speculation

The Price per Share of Fisher & Paykel Healthcare Corporation Limited is $20.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fisher & Paykel Healthcare Corporation Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fisher & Paykel Healthcare Corporation Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.76. Based on the TTM, the Book Value Change Per Share is $0.01 per quarter. Based on the YOY, the Book Value Change Per Share is $0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.15 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fisher & Paykel Healthcare Corporation Limited.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps0.130.6%0.130.6%0.251.2%0.251.2%0.311.5%0.241.2%
Usd Book Value Change Per Share0.010.0%0.010.0%0.070.4%0.080.4%0.160.8%0.130.6%
Usd Dividend Per Share0.150.7%0.150.7%0.200.9%0.190.9%0.180.9%0.130.6%
Usd Total Gains Per Share0.150.7%0.150.7%0.271.3%0.271.3%0.341.6%0.271.3%
Usd Price Per Share15.28-15.28-15.22-15.59-17.48-12.03-
Price to Earnings Ratio115.19-115.19-60.78-73.03-65.04-50.88-
Price-to-Total Gains Ratio101.10-101.10-56.47-66.64-67.69-54.31-
Price to Book Ratio8.68-8.68-8.68-9.01-12.09-10.30-
Price-to-Total Gains Ratio101.10-101.10-56.47-66.64-67.69-54.31-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.7
Number of shares48
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.150.18
Usd Book Value Change Per Share0.010.16
Usd Total Gains Per Share0.150.34
Gains per Quarter (48 shares)7.2516.34
Gains per Year (48 shares)29.0265.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
128119343155
2562486962120
38437710393185
41124106137124250
51405135172155315
61686164206186380
71968193240217445
82249222275248510
925210251309279575
1027911280343310640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%25.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%21.04.00.084.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%25.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.01.00.096.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Fisher & Paykel Healthcare Corporation Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0060.0060%0.074-92%0.079-93%0.162-97%0.132-96%
Book Value Per Share--1.7601.7600%1.754+0%1.731+2%1.538+14%1.125+56%
Current Ratio--1.8311.8310%2.671-31%2.475-26%2.225-18%2.236-18%
Debt To Asset Ratio--0.2290.2290%0.205+12%0.212+8%0.245-7%0.256-11%
Debt To Equity Ratio--0.2970.2970%0.257+15%0.270+10%0.329-10%0.348-15%
Dividend Per Share--0.1460.1460%0.196-26%0.189-23%0.179-19%0.134+8%
Enterprise Value--8698446271.5208698446271.5200%8727465061.7600%8958653414.453-3%10082694871.712-14%7700071091.255+13%
Eps--0.1330.1330%0.250-47%0.253-48%0.314-58%0.240-45%
Ev To Ebitda Ratio--40.28740.2870%34.317+17%33.745+19%33.968+19%30.876+30%
Ev To Sales Ratio--8.4378.4370%9.369-10%9.206-8%10.617-21%9.700-13%
Free Cash Flow Per Share--0.0910.0910%-0.211+333%-0.097+207%-0.129+243%-0.034+137%
Free Cash Flow To Equity Per Share---0.038-0.0380%-0.409+972%-0.284+646%-0.311+716%-0.172+351%
Gross Profit Margin---2.716-2.7160%-0.726-73%-1.162-57%-0.684-75%-0.639-76%
Intrinsic Value_10Y_max--3.828----------
Intrinsic Value_10Y_min---1.206----------
Intrinsic Value_1Y_max--0.056----------
Intrinsic Value_1Y_min---0.128----------
Intrinsic Value_3Y_max--0.418----------
Intrinsic Value_3Y_min---0.382----------
Intrinsic Value_5Y_max--1.081----------
Intrinsic Value_5Y_min---0.628----------
Market Cap12133077465.600+26%8956814111.5208956814111.5200%8921035701.760+0%9136156694.453-2%10247004151.712-13%7053077551.582+27%
Net Profit Margin--0.0750.0750%0.158-52%0.154-51%0.191-61%0.189-60%
Operating Margin--0.1440.1440%0.211-31%0.222-35%0.266-46%0.291-50%
Operating Ratio--0.8550.8550%0.848+1%0.826+4%0.782+9%0.790+8%
Pb Ratio11.763+26%8.6838.6830%8.676+0%9.012-4%12.094-28%10.304-16%
Pe Ratio156.050+26%115.190115.1900%60.780+90%73.031+58%65.044+77%50.882+126%
Price Per Share20.700+26%15.28015.2800%15.220+0%15.587-2%17.482-13%12.033+27%
Price To Free Cash Flow Ratio228.391+26%168.590168.5900%-71.998+143%0.292+57734%-45.438+127%-8.546+105%
Price To Total Gains Ratio136.961+26%101.100101.1000%56.471+79%66.643+52%67.687+49%54.308+86%
Quick Ratio--0.8810.8810%1.173-25%1.413-38%1.526-42%1.564-44%
Return On Assets--0.0580.0580%0.114-49%0.117-50%0.161-64%0.166-65%
Return On Equity--0.0750.0750%0.143-47%0.148-49%0.216-65%0.225-66%
Total Gains Per Share--0.1510.1510%0.270-44%0.268-44%0.340-56%0.267-43%
Usd Book Value--1031536240.0001031536240.0000%1028193760.000+0%1014902026.667+2%901519632.000+14%659356529.277+56%
Usd Book Value Change Per Share--0.0060.0060%0.074-92%0.079-93%0.162-97%0.132-96%
Usd Book Value Per Share--1.7601.7600%1.754+0%1.731+2%1.538+14%1.125+56%
Usd Dividend Per Share--0.1460.1460%0.196-26%0.189-23%0.179-19%0.134+8%
Usd Enterprise Value--8698446271.5208698446271.5200%8727465061.7600%8958653414.453-3%10082694871.712-14%7700071091.255+13%
Usd Eps--0.1330.1330%0.250-47%0.253-48%0.314-58%0.240-45%
Usd Free Cash Flow--53127840.00053127840.0000%-123906320.000+333%-56783066.667+207%-75751152.000+243%-19854781.614+137%
Usd Free Cash Flow Per Share--0.0910.0910%-0.211+333%-0.097+207%-0.129+243%-0.034+137%
Usd Free Cash Flow To Equity Per Share---0.038-0.0380%-0.409+972%-0.284+646%-0.311+716%-0.172+351%
Usd Market Cap12133077465.600+26%8956814111.5208956814111.5200%8921035701.760+0%9136156694.453-2%10247004151.712-13%7053077551.582+27%
Usd Price Per Share20.700+26%15.28015.2800%15.220+0%15.587-2%17.482-13%12.033+27%
Usd Profit--77756640.00077756640.0000%146775920.000-47%148515573.333-48%184282064.000-58%140527828.000-45%
Usd Revenue--1030949840.0001030949840.0000%931555040.000+11%975202746.667+6%962950896.000+7%737650797.040+40%
Usd Total Gains Per Share--0.1510.1510%0.270-44%0.268-44%0.340-56%0.267-43%
 EOD+4 -4MRQTTM+0 -0YOY+14 -263Y+13 -275Y+15 -2510Y+21 -19

3.3 Fundamental Score

Let's check the fundamental score of Fisher & Paykel Healthcare Corporation Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15156.050
Price to Book Ratio (EOD)Between0-111.763
Net Profit Margin (MRQ)Greater than00.075
Operating Margin (MRQ)Greater than00.144
Quick Ratio (MRQ)Greater than10.881
Current Ratio (MRQ)Greater than11.831
Debt to Asset Ratio (MRQ)Less than10.229
Debt to Equity Ratio (MRQ)Less than10.297
Return on Equity (MRQ)Greater than0.150.075
Return on Assets (MRQ)Greater than0.050.058
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Fisher & Paykel Healthcare Corporation Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.521
Ma 20Greater thanMa 5017.937
Ma 50Greater thanMa 10017.664
Ma 100Greater thanMa 20020.786
OpenGreater thanClose20.700
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Fundamental data was last updated by Penke on 2025-04-23 04:49:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Fisher & Paykel Healthcare Corporation Limited earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Fisher & Paykel Healthcare Corporation Limited to theΒ Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 7.5%Β means thatΒ $0.08 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 7.5%. The company is making a profit. +1
  • The TTM is 7.5%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ7.5%TTM7.5%0.0%
TTM7.5%YOY15.8%-8.2%
TTM7.5%5Y19.1%-11.6%
5Y19.1%10Y18.9%+0.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ7.5%5.5%+2.0%
TTM7.5%4.6%+2.9%
YOY15.8%6.8%+9.0%
3Y15.4%7.2%+8.2%
5Y19.1%6.9%+12.2%
10Y18.9%7.2%+11.7%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Fisher & Paykel Healthcare Corporation Limited is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Fisher & Paykel Healthcare Corporation Limited to theΒ Medical Instruments & Supplies industry mean.
  • 5.8% Return on Assets means thatΒ Fisher & Paykel Healthcare Corporation Limited generatedΒ $0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 5.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.8%TTM5.8%0.0%
TTM5.8%YOY11.4%-5.5%
TTM5.8%5Y16.1%-10.3%
5Y16.1%10Y16.6%-0.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8%1.0%+4.8%
TTM5.8%0.8%+5.0%
YOY11.4%1.3%+10.1%
3Y11.7%1.3%+10.4%
5Y16.1%1.5%+14.6%
10Y16.6%1.7%+14.9%
4.3.1.3. Return on Equity

Shows how efficient Fisher & Paykel Healthcare Corporation Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Fisher & Paykel Healthcare Corporation Limited to theΒ Medical Instruments & Supplies industry mean.
  • 7.5% Return on Equity means Fisher & Paykel Healthcare Corporation Limited generated $0.08Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 7.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.5%TTM7.5%0.0%
TTM7.5%YOY14.3%-6.7%
TTM7.5%5Y21.6%-14.1%
5Y21.6%10Y22.5%-0.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ7.5%2.7%+4.8%
TTM7.5%1.8%+5.7%
YOY14.3%2.7%+11.6%
3Y14.8%2.9%+11.9%
5Y21.6%3.4%+18.2%
10Y22.5%3.2%+19.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Fisher & Paykel Healthcare Corporation Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Fisher & Paykel Healthcare Corporation Limited is operatingΒ .

  • Measures how much profit Fisher & Paykel Healthcare Corporation Limited makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Fisher & Paykel Healthcare Corporation Limited to theΒ Medical Instruments & Supplies industry mean.
  • An Operating Margin of 14.4%Β means the company generated $0.14 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 14.4%. The company is operating less efficient.
  • The TTM is 14.4%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ14.4%TTM14.4%0.0%
TTM14.4%YOY21.1%-6.6%
TTM14.4%5Y26.6%-12.2%
5Y26.6%10Y29.1%-2.5%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ14.4%7.9%+6.5%
TTM14.4%6.8%+7.6%
YOY21.1%7.6%+13.5%
3Y22.2%7.8%+14.4%
5Y26.6%9.0%+17.6%
10Y29.1%10.1%+19.0%
4.3.2.2. Operating Ratio

Measures how efficient Fisher & Paykel Healthcare Corporation Limited is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.86 means that the operating costs are $0.86 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.855. The company is less efficient in keeping operating costs low.
  • The TTM is 0.855. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.855TTM0.8550.000
TTM0.855YOY0.848+0.007
TTM0.8555Y0.782+0.073
5Y0.78210Y0.790-0.007
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8551.128-0.273
TTM0.8551.104-0.249
YOY0.8481.021-0.173
3Y0.8261.055-0.229
5Y0.7821.056-0.274
10Y0.7900.998-0.208
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Fisher & Paykel Healthcare Corporation Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.83Β means the company has $1.83 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 1.831. The company is able to pay all its short-term debts. +1
  • The TTM is 1.831. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.831TTM1.8310.000
TTM1.831YOY2.671-0.841
TTM1.8315Y2.225-0.394
5Y2.22510Y2.236-0.011
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8312.111-0.280
TTM1.8312.085-0.254
YOY2.6712.554+0.117
3Y2.4752.512-0.037
5Y2.2252.689-0.464
10Y2.2362.603-0.367
4.4.3.2. Quick Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Fisher & Paykel Healthcare Corporation Limited to theΒ Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.88Β means the company can pay off $0.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.881. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.881. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.881TTM0.8810.000
TTM0.881YOY1.173-0.292
TTM0.8815Y1.526-0.645
5Y1.52610Y1.564-0.038
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8810.949-0.068
TTM0.8811.061-0.180
YOY1.1731.172+0.001
3Y1.4131.310+0.103
5Y1.5261.498+0.028
10Y1.5641.668-0.104
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Fisher & Paykel Healthcare Corporation Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Fisher & Paykel Healthcare Corporation LimitedΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Fisher & Paykel Healthcare Corporation Limited to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.23Β means that Fisher & Paykel Healthcare Corporation Limited assets areΒ financed with 22.9% credit (debt) and the remaining percentage (100% - 22.9%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.229. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.229. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.229TTM0.2290.000
TTM0.229YOY0.205+0.024
TTM0.2295Y0.245-0.016
5Y0.24510Y0.256-0.011
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2290.389-0.160
TTM0.2290.371-0.142
YOY0.2050.345-0.140
3Y0.2120.347-0.135
5Y0.2450.358-0.113
10Y0.2560.375-0.119
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Fisher & Paykel Healthcare Corporation Limited is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Fisher & Paykel Healthcare Corporation Limited to theΒ Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 29.7% means that company has $0.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.297. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.297. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.297TTM0.2970.000
TTM0.297YOY0.257+0.040
TTM0.2975Y0.329-0.032
5Y0.32910Y0.348-0.019
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2970.598-0.301
TTM0.2970.597-0.300
YOY0.2570.538-0.281
3Y0.2700.550-0.280
5Y0.3290.571-0.242
10Y0.3480.666-0.318
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Fisher & Paykel Healthcare Corporation Limited generates.

  • Above 15 is considered overpriced butΒ always compareΒ Fisher & Paykel Healthcare Corporation Limited to theΒ Medical Instruments & Supplies industry mean.
  • A PE ratio of 115.19 means the investor is paying $115.19Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 156.050. Based on the earnings, the company is expensive. -2
  • The MRQ is 115.190. Based on the earnings, the company is expensive. -2
  • The TTM is 115.190. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD156.050MRQ115.190+40.859
MRQ115.190TTM115.1900.000
TTM115.190YOY60.780+54.410
TTM115.1905Y65.044+50.146
5Y65.04410Y50.882+14.162
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD156.05013.961+142.089
MRQ115.19015.324+99.866
TTM115.19015.666+99.524
YOY60.78019.364+41.416
3Y73.03119.721+53.310
5Y65.04422.342+42.702
10Y50.88222.404+28.478
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 228.391. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 168.590. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 168.590. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD228.391MRQ168.590+59.801
MRQ168.590TTM168.5900.000
TTM168.590YOY-71.998+240.588
TTM168.5905Y-45.438+214.028
5Y-45.43810Y-8.546-36.893
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD228.39111.181+217.210
MRQ168.59012.106+156.484
TTM168.5909.530+159.060
YOY-71.9985.178-77.176
3Y0.292-0.600+0.892
5Y-45.4382.348-47.786
10Y-8.546-2.194-6.352
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Fisher & Paykel Healthcare Corporation Limited is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 8.68 means the investor is paying $8.68Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 11.763. Based on the equity, the company is expensive. -2
  • The MRQ is 8.683. Based on the equity, the company is overpriced. -1
  • The TTM is 8.683. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD11.763MRQ8.683+3.080
MRQ8.683TTM8.6830.000
TTM8.683YOY8.676+0.007
TTM8.6835Y12.094-3.411
5Y12.09410Y10.304+1.790
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD11.7632.371+9.392
MRQ8.6832.507+6.176
TTM8.6832.828+5.855
YOY8.6762.844+5.832
3Y9.0123.058+5.954
5Y12.0943.680+8.414
10Y10.3044.263+6.041
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-03-312021-03-312022-03-312023-03-312024-03-31
Other Stockholders Equity  36,415105,845142,261-3,108139,1536,978146,131-149,122-2,991
Total Other Income Expense Net 24,92241,86966,79111,72878,519-27,32651,193-62,158-10,966



6.2. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in NZD. All numbers in thousands.

Summary
Total Assets2,281,700
Total Liabilities522,600
Total Stockholder Equity1,759,100
 As reported
Total Liabilities 522,600
Total Stockholder Equity+ 1,759,100
Total Assets = 2,281,700

Assets

Total Assets2,281,700
Total Current Assets704,900
Long-term Assets1,576,800
Total Current Assets
Cash And Cash Equivalents 82,000
Net Receivables 257,200
Inventory 320,400
Other Current Assets 45,300
Total Current Assets  (as reported)704,900
Total Current Assets  (calculated)704,900
+/-0
Long-term Assets
Property Plant Equipment 1,340,000
Intangible Assets 88,400
Long-term Assets Other 55,900
Long-term Assets  (as reported)1,576,800
Long-term Assets  (calculated)1,484,300
+/- 92,500

Liabilities & Shareholders' Equity

Total Current Liabilities385,000
Long-term Liabilities137,600
Total Stockholder Equity1,759,100
Total Current Liabilities
Short-term Debt 96,200
Short Long Term Debt 78,500
Accounts payable 32,400
Other Current Liabilities 237,900
Total Current Liabilities  (as reported)385,000
Total Current Liabilities  (calculated)445,000
+/- 60,000
Long-term Liabilities
Long term Debt 35,700
Capital Lease Obligations 74,900
Long-term Liabilities  (as reported)137,600
Long-term Liabilities  (calculated)110,600
+/- 27,000
Total Stockholder Equity
Common Stock409,100
Retained Earnings 1,095,000
Accumulated Other Comprehensive Income 260,100
Other Stockholders Equity -5,100
Total Stockholder Equity (as reported)1,759,100
Total Stockholder Equity (calculated)1,759,100
+/-0
Other
Capital Stock404,000
Cash and Short Term Investments 82,000
Common Stock Shares Outstanding 586,179
Current Deferred Revenue18,500
Liabilities and Stockholders Equity 2,281,700
Net Debt 107,100
Net Invested Capital 1,873,300
Net Working Capital 319,900
Property Plant and Equipment Gross 1,899,700
Short Long Term Debt Total 189,100



6.3. Balance Sheets Structured

Currency in NZD. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-31
> Total Assets 
459,219
285,467
260,702
251,506
258,372
250,449
312,010
310,692
385,499
506,720
617,391
701,260
725,818
770,604
678,971
677,421
850,972
956,619
1,087,269
1,257,029
1,435,000
2,075,000
2,107,000
2,204,500
2,281,700
2,281,7002,204,5002,107,0002,075,0001,435,0001,257,0291,087,269956,619850,972677,421678,971770,604725,818701,260617,391506,720385,499310,692312,010250,449258,372251,506260,702285,467459,219
   > Total Current Assets 
221,164
196,760
170,201
147,079
141,213
138,821
146,211
133,680
150,605
211,482
234,014
252,654
247,454
268,027
253,091
246,053
317,083
380,260
449,926
474,290
518,700
920,000
887,900
774,200
704,900
704,900774,200887,900920,000518,700474,290449,926380,260317,083246,053253,091268,027247,454252,654234,014211,482150,605133,680146,211138,821141,213147,079170,201196,760221,164
       Cash And Cash Equivalents 
2,622
123,232
88,756
14,663
35,243
25,073
19,311
8,757
6,117
6,693
8,956
8,278
7,934
9,603
11,244
13,776
20,798
66,721
33,835
50,210
67,100
97,300
89,900
121,000
82,000
82,000121,00089,90097,30067,10050,21033,83566,72120,79813,77611,2449,6037,9348,2788,9566,6936,1178,75719,31125,07335,24314,66388,756123,2322,622
       Short-term Investments 
0
0
0
38,481
19,593
15,224
13,998
0
3,330
7,662
27,867
20,148
26,708
35,329
35,699
24,046
12,789
21,056
106,489
96,358
77,700
280,300
200,000
468
0
0468200,000280,30077,70096,358106,48921,05612,78924,04635,69935,32926,70820,14827,8677,6623,330013,99815,22419,59338,481000
       Net Receivables 
90,789
41,128
53,463
58,078
47,653
59,358
64,587
66,118
70,043
99,199
92,840
107,873
97,862
101,602
100,568
108,636
145,780
141,220
154,854
164,486
222,700
222,500
174,400
218,500
257,200
257,200218,500174,400222,500222,700164,486154,854141,220145,780108,636100,568101,60297,862107,87392,84099,19970,04366,11864,58759,35847,65358,07853,46341,12890,789
       Inventory 
72,907
22,035
23,265
24,026
27,749
33,608
42,217
52,822
59,010
85,666
93,264
108,522
107,124
111,008
101,766
97,235
134,224
147,037
133,005
141,777
146,500
270,600
358,900
365,800
320,400
320,400365,800358,900270,600146,500141,777133,005147,037134,22497,235101,766111,008107,124108,52293,26485,66659,01052,82242,21733,60827,74924,02623,26522,03572,907
       Other Current Assets 
54,846
10,364
4,718
11,182
9,737
5,556
6,099
5,983
15,434
19,924
38,954
27,982
34,534
45,814
39,513
26,407
16,280
25,282
21,743
21,459
4,700
49,300
64,700
76,227
45,300
45,30076,22764,70049,3004,70021,45921,74325,28216,28026,40739,51345,81434,53427,98238,95419,92415,4345,9836,0995,5569,73711,1824,71810,36454,846
   > Long-term Assets 
0
88,707
90,500
104,427
117,160
111,628
165,799
177,012
234,894
295,238
383,377
448,606
478,364
502,577
425,880
431,367
533,890
576,360
637,343
782,740
916,300
1,155,000
1,219,100
1,430,300
1,576,800
1,576,8001,430,3001,219,1001,155,000916,300782,740637,343576,360533,890431,367425,880502,577478,364448,606383,377295,238234,894177,012165,799111,628117,160104,42790,50088,7070
       Property Plant Equipment 
177,667
71,056
76,559
78,555
82,460
90,148
149,660
160,494
216,757
250,530
303,170
344,481
395,395
431,914
376,753
371,600
432,375
463,130
505,292
626,483
735,300
882,100
957,800
1,148,200
1,340,000
1,340,0001,148,200957,800882,100735,300626,483505,292463,130432,375371,600376,753431,914395,395344,481303,170250,530216,757160,494149,66090,14882,46078,55576,55971,056177,667
       Goodwill 
1,657
3,564
1,133
2,402
2,075
1,539
1,202
730
1,197
1,261
1,339
1,395
1,307
1,806
1,562
1,466
0
0
0
0
0
0
0
0
0
0000000001,4661,5621,8061,3071,3951,3391,2611,1977301,2021,5392,0752,4021,1333,5641,657
       Long Term Investments 
56,740
45,568
-889
0
0
0
0
0
0
0
0
0
0
0
777
17
10
22,059
900
400
0
0
0
0
0
0000040090022,059101777700000000000-88945,56856,740
       Intangible Assets 
0
0
5,147
1,939
2,573
2,590
2,631
2,524
3,786
4,212
5,018
5,907
6,846
8,939
9,646
21,218
39,682
48,447
53,457
64,065
73,900
80,000
86,800
85,600
88,400
88,40085,60086,80080,00073,90064,06553,45748,44739,68221,2189,6468,9396,8465,9075,0184,2123,7862,5242,6312,5902,5731,9395,14700
       Long-term Assets Other 
0
14,087
4,534
13,003
14,257
0
304
1,570
1,327
5,097
15,031
23,993
15,071
10,704
3,559
3,669
7,863
4,971
41,789
49,600
0
111,600
90,900
99,900
55,900
55,90099,90090,900111,600049,60041,7894,9717,8633,6693,55910,70415,07123,99315,0315,0971,3271,570304014,25713,0034,53414,0870
> Total Liabilities 
267,796
102,026
52,604
39,509
37,974
41,626
74,048
91,797
158,077
256,504
236,392
276,811
284,085
306,905
241,506
200,881
249,846
235,907
279,693
305,741
461,200
554,100
427,300
451,100
522,600
522,600451,100427,300554,100461,200305,741279,693235,907249,846200,881241,506306,905284,085276,811236,392256,504158,07791,79774,04841,62637,97439,50952,604102,026267,796
   > Total Current Liabilities 
152,655
75,625
50,558
38,224
35,076
40,622
72,722
90,625
128,297
114,947
127,117
114,045
191,109
113,446
138,730
118,444
165,936
158,581
189,219
192,091
334,600
427,500
303,900
289,800
385,000
385,000289,800303,900427,500334,600192,091189,219158,581165,936118,444138,730113,446191,109114,045127,117114,947128,29790,62572,72240,62235,07638,22450,55875,625152,655
       Short-term Debt 
94,465
10,356
9,024
3,415
7,291
8,770
27,811
46,202
75,558
28,716
31,843
23,181
101,795
21,347
49,320
14,315
18,074
22,975
31,713
18,022
92,200
26,600
17,000
21,300
96,200
96,20021,30017,00026,60092,20018,02231,71322,97518,07414,31549,32021,347101,79523,18131,84328,71675,55846,20227,8118,7707,2913,4159,02410,35694,465
       Short Long Term Debt 
94,465
77,052
2,727
0
0
0
0
0
0
0
0
0
0
0
112,740
1,374
2,105
21,091
29,900
17,300
80,600
11,900
5,300
4,200
78,500
78,5004,2005,30011,90080,60017,30029,90021,0912,1051,374112,740000000000002,72777,05294,465
       Accounts payable 
26,468
10,247
10,130
9,540
12,459
16,393
22,366
17,993
17,039
28,998
29,647
28,610
28,555
26,333
25,013
27,977
41,020
31,938
34,683
57,398
69,300
56,700
53,800
43,000
32,400
32,40043,00053,80056,70069,30057,39834,68331,93841,02027,97725,01326,33328,55528,61029,64728,99817,03917,99322,36616,39312,4599,54010,13010,24726,468
       Other Current Liabilities 
31,722
4,055
8,976
23,904
13,009
13,647
17,907
10,856
28,955
44,256
48,087
41,689
44,398
49,919
58,897
75,231
95,714
94,546
115,982
85,623
137,700
194,600
201,200
218,900
237,900
237,900218,900201,200194,600137,70085,623115,98294,54695,71475,23158,89749,91944,39841,68948,08744,25628,95510,85617,90713,64713,00923,9048,9764,05531,722
   > Long-term Liabilities 
0
26,402
2,046
1,285
2,899
1,004
1,325
1,172
29,781
141,558
109,275
162,766
92,976
193,459
102,777
82,437
83,911
77,326
90,473
113,650
126,600
126,600
123,400
161,300
137,600
137,600161,300123,400126,600126,600113,65090,47377,32683,91182,437102,777193,45992,976162,766109,275141,55829,7811,1721,3251,0042,8991,2852,04626,4020
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,600
43,700
36,000
62,500
74,900
74,90062,50036,00043,70033,60000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,297
0
0
0
0
0
0
0
000000014,29700000000000000000
> Total Stockholder Equity
191,423
183,441
208,097
211,997
220,398
208,823
237,963
218,895
227,422
250,215
380,998
424,450
441,733
463,699
437,465
476,540
601,126
720,713
807,576
951,288
973,800
1,520,900
1,679,700
1,753,400
1,759,100
1,759,1001,753,4001,679,7001,520,900973,800951,288807,576720,713601,126476,540437,465463,699441,733424,450380,998250,215227,422218,895237,963208,823220,398211,997208,097183,441191,423
   Common Stock
0
183,441
208,097
188,081
201,188
212,728
238,250
218,895
4,239
4,992
16,895
52,457
80,321
113,710
129,663
147,527
181,163
198,069
210,432
228,342
225,400
249,100
261,200
303,700
409,100
409,100303,700261,200249,100225,400228,342210,432198,069181,163147,527129,663113,71080,32152,45716,8954,9924,239218,895238,250212,728201,188188,081208,097183,4410
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
-2,222
-4,554
-3,905
-287
0
3,893
15,308
109,301
121,732
127,921
107,174
65,964
59,213
56,122
96,686
101,504
150,839
62,100
242,600
237,300
249,200
260,100
260,100249,200237,300242,60062,100150,839101,50496,68656,12259,21365,964107,174127,921121,732109,30115,3083,8930-287-3,905-4,554-2,222000
   Capital Surplus 0000000000000000000000000
   Treasury Stock0000000000000000000000000
   Other Stockholders Equity 
0
0
-171,883
2,021
3,951
3,591
246
0
0
0
0
0
0
0
61,238
58,548
50,571
88,800
95,700
144,800
62,100
242,600
237,300
249,200
-5,100
-5,100249,200237,300242,60062,100144,80095,70088,80050,57158,54861,23800000002463,5913,9512,021-171,88300



6.4. Balance Sheets

Currency in NZD. All numbers in thousands.




6.5. Cash Flows

Currency in NZD. All numbers in thousands.




6.6. Income Statements

Currency in NZD. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in NZD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,758,100
Cost of Revenue-698,400
Gross Profit1,059,7001,059,700
 
Operating Income (+$)
Gross Profit1,059,700
Operating Expense-805,300
Operating Income254,400254,400
 
Operating Expense (+$)
Research Development198,200
Selling General Administrative492,800
Selling And Marketing Expenses492,800
Operating Expense805,3001,183,800
 
Net Interest Income (+$)
Interest Income3,300
Interest Expense-18,200
Other Finance Cost-0
Net Interest Income-14,900
 
Pretax Income (+$)
Operating Income254,400
Net Interest Income-14,900
Other Non-Operating Income Expenses-
Income Before Tax (EBT)235,700273,100
EBIT - interestExpense = 235,700
235,700
150,800
Interest Expense18,200
Earnings Before Interest and Taxes (EBIT)253,900253,900
Earnings Before Interest and Taxes (EBITDA)368,200
 
After tax Income (+$)
Income Before Tax235,700
Tax Provision-103,100
Net Income From Continuing Ops132,600132,600
Net Income132,600
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses1,503,700
Total Other Income/Expenses Net-18,70014,900
 

Technical Analysis of Fisher & Paykel Healthcare Corporation Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Fisher & Paykel Healthcare Corporation Limited. The general trend of Fisher & Paykel Healthcare Corporation Limited is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Fisher & Paykel Healthcare Corporation Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Fisher & Paykel Healthcare Corporation Limited Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Fisher & Paykel Healthcare Corporation Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 22.00 < 22.00 < 22.59.

The bearish price targets are: 18.36 > 16.93 > 16.93.

Know someone who trades $FSPKF? Share this with them.πŸ‘‡

Fisher & Paykel Healthcare Corporation Limited Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Fisher & Paykel Healthcare Corporation Limited. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Fisher & Paykel Healthcare Corporation Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Fisher & Paykel Healthcare Corporation Limited. The current macd is 0.45746988.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Fisher & Paykel Healthcare Corporation Limited price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Fisher & Paykel Healthcare Corporation Limited. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Fisher & Paykel Healthcare Corporation Limited price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Fisher & Paykel Healthcare Corporation Limited Daily Moving Average Convergence/Divergence (MACD) ChartFisher & Paykel Healthcare Corporation Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Fisher & Paykel Healthcare Corporation Limited. The current adx is 28.28.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Fisher & Paykel Healthcare Corporation Limited shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Fisher & Paykel Healthcare Corporation Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Fisher & Paykel Healthcare Corporation Limited. The current sar is 17.29.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Fisher & Paykel Healthcare Corporation Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Fisher & Paykel Healthcare Corporation Limited. The current rsi is 67.52. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Fisher & Paykel Healthcare Corporation Limited Daily Relative Strength Index (RSI) ChartFisher & Paykel Healthcare Corporation Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Fisher & Paykel Healthcare Corporation Limited. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Fisher & Paykel Healthcare Corporation Limited price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Fisher & Paykel Healthcare Corporation Limited Daily Stochastic Oscillator ChartFisher & Paykel Healthcare Corporation Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Fisher & Paykel Healthcare Corporation Limited. The current cci is 129.03.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Fisher & Paykel Healthcare Corporation Limited Daily Commodity Channel Index (CCI) ChartFisher & Paykel Healthcare Corporation Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Fisher & Paykel Healthcare Corporation Limited. The current cmo is 45.94.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Fisher & Paykel Healthcare Corporation Limited Daily Chande Momentum Oscillator (CMO) ChartFisher & Paykel Healthcare Corporation Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Fisher & Paykel Healthcare Corporation Limited. The current willr is -23.00884956.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Fisher & Paykel Healthcare Corporation Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Fisher & Paykel Healthcare Corporation Limited Daily Williams %R ChartFisher & Paykel Healthcare Corporation Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Fisher & Paykel Healthcare Corporation Limited.

Fisher & Paykel Healthcare Corporation Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Fisher & Paykel Healthcare Corporation Limited. The current atr is 0.55370317.

Fisher & Paykel Healthcare Corporation Limited Daily Average True Range (ATR) ChartFisher & Paykel Healthcare Corporation Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Fisher & Paykel Healthcare Corporation Limited. The current obv is -42,277.

Fisher & Paykel Healthcare Corporation Limited Daily On-Balance Volume (OBV) ChartFisher & Paykel Healthcare Corporation Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Fisher & Paykel Healthcare Corporation Limited. The current mfi is 12.62.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Fisher & Paykel Healthcare Corporation Limited Daily Money Flow Index (MFI) ChartFisher & Paykel Healthcare Corporation Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Fisher & Paykel Healthcare Corporation Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-18ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-24DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-02-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-03-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-03-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-07ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Fisher & Paykel Healthcare Corporation Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Fisher & Paykel Healthcare Corporation Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5067.521
Ma 20Greater thanMa 5017.937
Ma 50Greater thanMa 10017.664
Ma 100Greater thanMa 20020.786
OpenGreater thanClose20.700
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Fisher & Paykel Healthcare Corporation Limited with someone you think should read this too:
  • Are you bullish or bearish on Fisher & Paykel Healthcare Corporation Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Fisher & Paykel Healthcare Corporation Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Fisher & Paykel Healthcare Corporation Limited

I send you an email if I find something interesting about Fisher & Paykel Healthcare Corporation Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Fisher & Paykel Healthcare Corporation Limited.

Receive notifications about Fisher & Paykel Healthcare Corporation Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.